MedPath

AM-3101

Generic Name
AM-3101

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Phase 1
Recruiting
Conditions
Meniscus Tear
Interventions
Drug: Saline Placebo
First Posted Date
2022-09-29
Last Posted Date
2023-05-03
Lead Sponsor
University of Cincinnati
Target Recruit Count
74
Registration Number
NCT05560477
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath